• Working Hours - Mon - Thu: 8:00 - 17:00; Fri: 8:00 - 14:00
What are you looking for?

Category Archives: News And Articles

Ondo State, IHVN Partner on Malaria Prevention and Treatment

To curb mortality of pregnant women and children under five, the Ondo State government and Institute of Human Virology Nigeria (IHVN) have commenced implementation of the Immunization and Malaria Progress by Accelerating Coverage and Transforming Services (IMPACT) Project in the state.

The project which is funded by the World Bank will promote the use of Long-Lasting Insecticide Treated Nets (LLIN) by pregnant women and children under five years of age, strengthen the case management skills of both public and private providers on the Integrated Management of Childhood Diseases (IMCI) and sensitize households on the use of Intermittent Preventive Treatment of Malaria in Pregnancy (IPTp) and Seasonal Malaria Chemoprophylaxis (SMC).

At an onboarding of community-based organizations deployed to the 18 Local Government Areas for sensitization activities, Ondo IMPACT Project Manager, Dr Folayan Abolaji said that the goal for the project is to reduce under-five mortality in the state by 40%, from 15 per 1000 live births to less than 10 per 1000 live births.

“Also, for pregnant mothers, we want to prevent mortality amongst them and reduce the burden of malaria scourge among the general public. It is a project bringing several levels of interventions into the malaria program to give us a desirable outcome,” he said.

Dr. Abolaji added that survey findings from previous distribution of Long-Lasting Insecticide Treated Nets in the state showed excellent distribution of nets but poor utilization to prevent malaria.

“This program will see to it that while making provision for necessary interventions, commodities, and drugs, we engage CSOs and CBOs that will propagate and increase the utilization of these services because if they are not properly engaged, all that we have used a lot of money to make provision for will be wasted. We don’t want that to happen.”

He urged the CBOs to make the state proud by working in tandem with the mandate and terms of reference given by IHVN.

IHVN IMPACT Project Chief of Party, Dr. Temitope Kolade, noted that the Institute will closely collaborate with the state to achieve its set targets.

“We are working with local community-based organizations to ensure that we gain ownership and easy acceptance of the project in the state. We are also going to work with the existing community structures, the gatekeepers, ward development committees, and local government structures.

One of the key messages that the CBOs will be passing across is how to prevent malaria. One of the new things that we have put into the design of this project is the social behavior change communication so that we are passing across knowledge for acceptance and cooperation of beneficiaries,” she said.

A representative from the participating Community-Based Organizations (CBOs) High Chief Akomolafe Pius from Knowledge Care Providers, said that the meeting exposed the CBOs to varied strategies to engage the community.

“Proper community engagement will inform proper project implementation. We have been enriched with the knowledge to be taken to the grassroots. Without appropriate knowledge, you won’t be able to deliver on goals, because you have to mobilize, inform, and convince the people in the local governments to imbibe the culture of health-seeking behaviour,” Chief Akomolafe added.

Ending AIDS is a Collective Responsibility – IHVN CEO

As the world commemorates World AIDS Day 2024, the Institute of Human Virology Nigeria (IHVN) has urged stakeholders to collaborate to sustain investment and innovative approaches to addressing AIDS by 2030.

IHVN Chief Executive Officer, Dr. Patrick Dakum made this call at a press conference in Abuja organized by the National Agency for the Control of AIDS (NACA) to kick off the commemoration of World AIDS Day 2024.

Dr. Dakum, who was represented by the Project Director of the Global Fund N-THRIP project, Dr. Olayemi Olupitan said, “World AIDS Day serves as a reminder of our collective responsibility to ensure that no one is left behind in the fight against HIV/AIDS. This year’s theme, ‘Take the Rights Path: Sustain the HIV Response and Stop HIV among Children to End AIDS in Nigeria by 2030’ resonates deeply with our mission of promoting health equity and ensuring access to life-saving prevention, care, and treatment services for HIV and associated diseases. Our work has consistently focused on delivering patient-centered solutions, strengthening health systems, and reducing stigma and discrimination in communities.”

The CEO also noted that collective action will ensure a healthier, more equitable Nigeria.

While addressing the press at the event, NACA Director General, Dr. Temitope Ilori said that despite the country’s progress in combating HIV, prevention of mother-to-child transmission of HIV (PMTCT) and pediatric HIV coverage remains below 33%.

“Following comprehensive data analysis in 2021, we joined the international initiative and developed the Global Alliance Action Plan to End AIDS in Children. The plan is fully resourced, yet coverage continues to fall short. To address this, the Honourable Minister of State for Health recently established a national-level acceleration committee to track implementation,” she said.

Dr. Ilori called on Nigerians to join hands to break the stigma, embrace equity, drive collective action and stop HIV among children.

“We must empower every individual, especially women who are most vulnerable to contracting HIV and other vulnerable populations, to access life-saving services and live with dignity.”

Partners represented a the event include UNAIDS, US Presidents Emergency Plan for AIDS Relief (PEPFAR), Network of People Living with HIV (NEPWHAN), Association of Women Living with HIV (ASWHAN), Society for Family Health (SFH) and FHI 360.  

IHVN Bids Farewell to Board Director Hon. Tapgun

The Institute of Human Virology Nigeria (IHVN) recently joined family, friends, and well-wishers to bid farewell to Hon. Josephine Yinoe Tapgun, a cherished member of the IHVN Board, who passed away on 3rd November 2024.

The wake mass and funeral service in her honour were held at St Fimbars Catholic Church Rayfield, Jos, on November 14th and 15th, 2024, respectively.

IHVN Chief Executive Officer Dr. Patrick Dakum, who was represented at the event by IHVN Director Program Coordinating Unit, Dr. Yusuf Baba Oche, and IHVN Jos Regional Manager Mr. Timzing Miri-Dashe, conveyed the condolences of the Institute’s Board and Management to her family.

 Her family’s representative, Ambassador Sir Fidelis Tapgun, former Governor of Plateau State, expressed their gratitude to the Institute. He also thanked everyone who attended the ceremony and called for continued prayers for the family.

The event highlighted the Late Hon. Tapgun’s life of service and love and her positive impact on countless lives. Both the Plateau State Government Deputy Governor, Ms. Josephine Piyo, and the representative of the Plateau State Traditional Council, The Long-Gomai of Shendam, His Royal Highness Martins Shaldas, expressed sadness over her passing and noted that it was a loss to Plateau State and Nigeria at large.

Hon. Tapgun was widely respected for her unwavering commitment to humanity. As an IHVN Board Director, she was instrumental in advancing the organization’s mission to improve healthcare and empower communities across Nigeria.

IHVN Participates in Groundbreaking African-Led Initiative to Develop HIV Vaccine

The Institute of Human Virology Nigeria (IHVN) is participating in a groundbreaking African-led initiative to develop an HIV vaccine aimed at addressing the continent’s high burden of HIV infections.

Through its International Research Centre of Excellence (IRCE), IHVN is implementing the “Bringing Innovation to Clinical and Laboratory Research to End HIV in Africa through New Vaccine Technology” (BRILLIANT) project in Nigeria. The project is funded by a $45 million grant from the United States Agency for International Development (USAID) and led by the Chief Executive Officer and President of the South African Medical Research Council, Cape Town, South Africa, Prof. Glenda Gray

The initiative is part of the HIV Vaccine Innovation, Science, and Technology Acceleration in Africa (HIV-VISTA) program, includes Nigeria, South Africa, Zambia, Zimbabwe, Tanzania, Uganda, Kenya, and Mozambique, and it aims to tailor HIV vaccine solutions to meet the specific needs of African populations.

IRCE Executive Director, Professor Alash’le Abimiku, expressed optimism about the project’s potential emphasizing that it is an essential step towards reducing the continent’s dependency on external support by cultivating local expertise and fostering private-sector partnerships.

“Africa currently bears approximately 65 percent of the global HIV burden, with Nigeria ranking as the fourth highest in cases worldwide. In 2023, UNAIDS estimated nearly 40 million people were living with HIV globally, with 1.3 million new infections recorded. In Nigeria alone, 1.9 million people are affected by HIV, underscoring the urgent need for additional preventive tools like a vaccine.”

She stressed the importance of leveraging new vaccine technologies, such as mRNA, to keep Africa’s healthcare solutions modern: “We cannot be using outdated technologies of the 18th century. We have to employ current technologies, and this collaboration should bring that capacity to our continent. This is a true partnership that acknowledges Africa’s potential for innovation and science to solve global health challenges, especially those that disproportionately impact our continent.”

IHVN and the BRILLIANT consortium’s efforts focus on evaluating vaccine candidates originating from Africa, with plans to implement the research solely within Sub-Saharan Africa, the region most affected by the epidemic. The HIV-VISTA study and the BRILLIANT project aim to establish a sustainable foundation for HIV vaccine research and development within the continent, potentially saving millions of lives by advancing local solutions to one of Africa’s most significant health challenges.

The Director-General of the National Agency for the Control of AIDS (NACA), Temitope Ilori, stated that “the five-year research initiative aims to find an effective vaccine for HIV, a virus particularly prevalent among youths, which could contribute significantly to the goal of the Federal Ministry of Health in eradicating the virus. Nigeria is one of eight African countries commissioned to work on a vaccine suitable for our population. This clinical trial, part of the BRILLIANT Study, is a crucial step toward ending HIV in Africa.”

Also at the event, UNAIDS Country Director Dr. Leo Zekeng, applauded the initiative as a groundbreaking step in global AIDS prevention. “At the core of our global strategy is ending inequalities and ending AIDS by 2030.  Promoting science, research, and development is part of this effort and this initiative is tailored for Africa’s population and empowers local scientists to continue the fight against HIV. He expressed appreciation for USAID’s support, describing it as “sa vital investment in Africa’s healthcare future.”